HealthWell Foundation launches fund for underinsured multiple myeloma patients

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE HEALTHWELL FOUNDATION launched a fund to provide financial assistance to underinsured patients suffering from multiple myeloma, providing grants up to $10,000 to assist patients with copayment or premium costs.

Multiple myeloma patients who are insured and have annual household incomes up to 500 percent of the federal poverty level are eligible under the fund. http://www.HealthWellFoundation.org

“A substantial number of multiple myeloma patients face significant hardship when it comes to treatment choices and the ability to cover out-of-pocket drug copayment and premium expenses,” said Sharon Saias, Vice President Marketing and Communications, Multiple Myeloma Research Foundation. “The financial lifeline being offered through the HealthWell Foundation addresses a critical need for these patients and allows them to access medical treatments that are vital to managing their disease.”

Table of Contents

YOU MAY BE INTERESTED IN

At the Sept. 4 meeting of the National Cancer Advisory Board, NCI Principal Deputy Director Douglas R. Lowy provided an overview of how NCI is weathering the maelstrom of executive orders, policy changes, and funding uncertainties that has come down on federal agencies and research institutes since Donald Trump’s inauguration in January. 
A Senate hearing that the administration hoped would be a routine check-in on the president’s 2026 MAHA-driven healthcare agenda erupted into a political firestorm as senators jumped at their first opportunity to confront HHS Secretary Robert F. Kennedy Jr. over the chaos engulfing the Centers for Disease Control and Prevention.
In December 1971, President Richard Nixon signed the National Cancer Act and declared a “War on Cancer.” In the past 54 years, the U.S. has invested $180 billion nominally, or approximately $322 billion when adjusted for inflation, in cancer research. This investment has paid dividends with more than 100 anticancer drugs brought to market in half a century—virtually all traceable to National Cancer Institute funding. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login